L1 Capital Global Opportunities Master Fund, Ltd. filed a Schedule 13G/A on August 14, 2026, regarding its holdings in Jiuzi Holdings, Inc. (JZXN). The filing indicates that the reporting person now beneficially owns 988,305 Ordinary Shares, representing 1.9% of the company based on 51,512,759 shares outstanding as of ...

This Schedule 13G/A (Amendment No. 2) filed by Vyacheslav Kim details his significant ownership stake in Joint Stock Company Kaspi.kz (KSPI). As of the event date of June 30, 2026, the reporting person beneficially owned 38,095,117 Common Shares, representing 20.0% of the company's outstanding shares. These holdings ar...

Lynwood Capital Management Inc., alongside Ben Shapiro and Lynwood Opportunities Master Fund, filed an amended Schedule 13G on August 14, 2026, regarding their holdings in Kazia Therapeutics Limited (KZIA). The filing indicates that as of June 30, 2026, the reporting persons beneficially own 264,980,500 ordinary shares...

On August 14, 2026, T. Rowe Price Associates, Inc. filed a Schedule 13G/A with the SEC, reporting a significant increase in its stake in Kestra Medical Technologies (KMTS). The investment advisor now beneficially owns 4,968,900 shares of common stock, representing an 8.5% ownership stake in the company. This reflects a...

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, filed a Schedule 13G/A on August 14, 2026, disclosing a significant increase in their position in Kiora Pharmaceuticals, Inc. (KPRX). As of the event date of June 30, 2026, the reporting persons are deemed to beneficial...

Yield Point NY LLC and Yisroel Ari Kluger have filed Amendment No. 2 to their Schedule 13G regarding their holdings in Kustom Entertainment, Inc. (DGLY). As of June 30, 2026, the reporting persons disclosed beneficial ownership of 41,581 shares of Common Stock, representing a 1.4% ownership stake based on 2,856,860 sha...

SilverArc Capital Management, LLC, along with its sole member Devesh Gandhi, has filed a Schedule 13G/A indicating a complete exit from their position in KalVista Pharmaceuticals, Inc. (KALV). As of the event date of June 30, 2026, the reporting persons beneficially own zero shares of the company's Class A Common Stock...

Tang Capital Management, LLC, along with Kevin Tang and several affiliated entities including Tang Capital Partners, LP, Tang Capital Partners International, LP, Tang Capital Partners III, Inc., and Tang Capital Partners IV, Inc., has filed an amendment to their Schedule 13G regarding KalVista Pharmaceuticals, Inc. (KA...

Venrock Healthcare Capital Partners III, L.P. and its affiliates, including VHCP Co-Investment Holdings III, LLC and Venrock Healthcare Capital Partners EG, L.P., filed an amendment to their Schedule 13G regarding KalVista Pharmaceuticals, Inc. (KALV). According to the filing dated August 14, 2026, with an event date o...

Karpus Management, Inc. (d/b/a Karpus Investment Management) filed a Schedule 13G/A on August 14, 2026, disclosing an increased ownership stake in Western Asset Investment Grade Opportunity Trust Inc. (IGI). As of the event date of June 30, 2026, the reporting person beneficially owns 529,003 shares of common stock, re...

Karpus Management, Inc. (doing business as Karpus Investment Management) filed a Schedule 13G/A on August 14, 2026, disclosing a 6.4% ownership stake in Lake Superior Acquisition Corp (LKSP). The reporting person holds 1,249,608 shares of common stock as of the event date of June 30, 2026. This filing represents an inc...

On August 14, 2026, Karpus Management, Inc. (d/b/a Karpus Investment Management) filed a Schedule 13G/A with the SEC, reporting a significant increase in its position in NMP Acquisition Corp. (NMP). As of the event date of June 30, 2026, Karpus Management beneficially owns 849,065 shares of common stock, representing a...

Karpus Management, Inc. (d/b/a Karpus Investment Management) filed a Schedule 13G/A on August 14, 2026, disclosing a 6.08% ownership stake in Oxford Lane Capital Corp. (OXLC). As of the event date on June 30, 2026, the reporting person beneficially owns 887,243 shares of the issuer's preferred stock. This filing repres...

Karpus Management, Inc. (d/b/a Karpus Investment Management) filed a Schedule 13G/A on August 14, 2026, disclosing an increased position in Oxford Lane Capital Corp. (OXLC). As of the event date on June 30, 2026, the reporting person beneficially owns 288,716 shares of the issuer's preferred stock, representing a 1.98%...

Karpus Management, Inc. (d/b/a Karpus Investment Management) filed a Schedule 13G/A on August 14, 2026, disclosing a 4.3% ownership stake in Oxford Lane Capital Corp. (OXLC). As of the event date on June 30, 2026, the reporting person beneficially owns 628,269 shares of the issuer's preferred stock. Karpus reports sole...

Karpus Management, Inc. (d/b/a Karpus Investment Management) filed a Schedule 13G/A on August 14, 2026, disclosing a position in Oxford Lane Capital Corp. (OXLC). As of the event date of June 30, 2026, the reporting person beneficially owns 528,559 shares of Preferred stock, representing a 3.62% ownership stake in the ...

Karpus Management, Inc. (d/b/a Karpus Investment Management) filed a Schedule 13G/A on August 14, 2026, disclosing a significant stake in Quartzsea Acquisition Corp (QSEA). As of the event date of June 30, 2026, the reporting person beneficially owns 974,765 shares of common stock, representing 9.62% of the company. Th...

RA Capital Management, L.P., along with Peter Kolchinsky and Rajeev Shah, filed a Schedule 13G/A on August 14, 2026, disclosing a 9.9% stake in Karyopharm Therapeutics Inc. (KPTI). As of the event date of June 30, 2026, the reporting persons beneficially owned 2,302,504 shares of common stock. The holdings include 1,91...

Koch Companies Defined Benefit Master Trust (Koch Pension) and Koch, Inc. have filed a Schedule 13G/A reporting a significant ownership stake in Kayne Anderson BDC, Inc. (KBDC). As of June 30, 2026, the reporting persons beneficially own 8,700,507 shares of common stock, representing 13.2% of the company's outstanding ...

T. Rowe Price Associates, Inc. has filed a Schedule 13G/A with the SEC, reporting a significant stake in Keysight Technologies, Inc. (KEYS). As of June 30, 2026, the investment firm beneficially owns 9,620,744 shares of common stock, representing a 5.6% ownership interest in the company. This filing marks an increase i...

T. Rowe Price Associates, Inc. filed a Schedule 13G/A on August 14, 2026, disclosing an increased stake in Knife River Corp (KNF). As of the event date on June 30, 2026, the investment firm reported beneficial ownership of 5,116,450 shares of common stock, representing a 9.0% ownership interest in the company. This fil...

Soros Fund Management LLC and George Soros have filed a Schedule 13G/A reporting a new beneficial ownership position in Kodiak AI, Inc. (KDK). As of the event date of June 30, 2026, the reporting persons beneficially own 9,767,037 shares of Common Stock, representing 4.9% of the company's outstanding shares. This filin...

Montanova Capital, LLC, Averill Master Fund, Ltd., and Aaron Cowen have filed Amendment No. 6 to their Schedule 13G regarding their holdings in Kura Oncology, Inc. As of the event date of June 30, 2026, the reporting group collectively beneficially owns 8,575,422 shares of Common Stock, representing a 9.7% ownership st...

T. Rowe Price Associates, Inc. filed a Schedule 13G/A on August 14, 2026, disclosing an increased ownership stake in Kymera Therapeutics Inc (KYMR). As of the event date on June 30, 2026, the investment adviser reported beneficial ownership of 7,112,345 shares of common stock, representing 8.6% of the company. This fil...

Kynam Capital Management, LP, along with Kynam Capital Management GP, LLC and Yue Tang, filed a Schedule 13G/A on August 14, 2026, regarding their holdings in Vera Therapeutics, Inc. (VERA). The filing indicates that as of June 30, 2026, the reporting persons collectively hold 2,890,059 shares of Class A common stock, ...